Pharma News - Chemdiv

Sirana Pharma and Pfizer to work on treatment for brittle bone disease

German biotech company Sirana Pharma GmbH has entered into a collaborative research agreement with Pfizer Inc. to investigate the potential identification and validation of a novel treatment concep...

After coeliac fail, 9 Meters plots phase 3 in short bowel syndrome

Two weeks after reporting disappointing results for its lead coeliac disease therapy, 9 Meters Biopharma will draw some comfort from a mid-stage trial of its candidate for short bowel syndrome (SBS...

Dramatic' surprise discovery finds cancer drug delays muscular dystrophy progression in mice

A new surprise discovery could hold big implications for muscular dystrophy patients, with researchers finding that an existing cancer drug may delay progression of the hard-to-treat disease. ...

Fast and facile synthesis of antibacterial amino acid Schiff base copper complexes

Ever since their development in the late 19th century, Schiff bases have been a popular group of organic compounds, owing to their wide variety of desirable properties. ...

Protecting the brain from dementia-inducing abnormal protein aggregates

In order to maintain cellular homeostasis (i.e., a state of equilibrium), cells undergo selective autophagy or self-degradation of unwanted proteins.

FDA Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for subgroup of Patients with Critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has declined to issue an Emergency Use Authoriz...

U.S. Government Inks $3.2 Billion Contract With Pfizer-BioNTech for Vaccine Booster Campaign

The U.S. government has signed a $3.2 billion COVID-19 vaccine supply agreement with Pfizer and BioNTech for 105 million doses.

FDA Pushes Back Review Period for Provention Bio's Diabetes Drug

Provention Bio will have to wait a little bit longer to see if the U.S. Food and Drug Administration will approve its diabetes prevention drug, teplizumab.

FDA rejection of Spero’s tebipenem ‘raises resistance threat’

The FDA’s decision not to approve Spero Therapeutics’ oral antibiotic tebipenem Hbr for adults with complicated urinary tract infections (cUTI) further increases the threat of antibiotic resis...

EU Approves Sanofi’s Xenpozyme and Nexviadyme

The European Commission has approved two Sanofi enzyme replacement therapies, Xenpozyme (olipudase alfa) and Nexviadyme (avalglucosidase alfa).

Pfizer asks for formal U.S. approval of oral COVID treatment Paxlovid

Pfizer Inc (PFE.N) said on Thursday it is seeking full U.S. approval for its oral COVID-19 antiviral treatment Paxlovid, which is currently available under an emergency use authorization (EUA). ...

Pollution linked to 10% of cancers in Europe

New calculations by the European Environmental Agency (EEA) have definitively proven the link between pollution and cancer.